Systasy is a next-generation service provider pioneering a new approach to drug discovery. We are offering the pathwayProfiler30, a tool to provide unprecendented insight into the most important functional intracellular pathways paving the way for both drug characterization and discoveries of novel druggable targets (Herholt et at., 2018). Pharma and biotech companies are increasingly picking up our services to identify novel target genes in complex diseases and characterize their proprietary compounds in depth.